Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Fuji
Colorcon
Moodys
US Army
Fish and Richardson
AstraZeneca
Boehringer Ingelheim
QuintilesIMS
Novartis

Generated: August 17, 2017

DrugPatentWatch Database Preview

Durata Theraps Intl Company Profile

« Back to Dashboard

What is the competitive landscape for DURATA THERAPS INTL, and when can generic versions of DURATA THERAPS INTL drugs launch?

DURATA THERAPS INTL has one approved drug.

There are four US patents protecting DURATA THERAPS INTL drugs.

There are fifty-three patent family members on DURATA THERAPS INTL drugs in sixteen countries.

Summary for Applicant: Durata Theraps Intl

Patents:4
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883-001May 23, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Durata Theraps Intl Drugs

Country Document Number Estimated Expiration
BrazilPI0510269► Subscribe
European Patent Office1565201► Subscribe
Hong Kong1083684► Subscribe
New Zealand588109► Subscribe
Israel239913► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Farmers Insurance
Boehringer Ingelheim
Dow
McKinsey
Queensland Health
Teva
Covington
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot